DUBLIN–(BUSINESS WIRE)–The “Cell
Isolation/Cell Separation Market by Product (Reagents, Beads,
Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow,
Adipose), Technique (Filtration), Application, End User (Hospitals,
Biotechnology) – Global Forecast to 2024” report has been added
to ResearchAndMarkets.com’s offering.
The market size for cell isolation is expected to reach USD 13.0 billion
by 2024 from USD 5.9 billion in 2019, at a CAGR of 17.2%
The growth in this market is attributed to the increasing number of
patients suffering from cancer and infectious diseases, increasing
government funding for cell-based research, technological advancements,
and the growing focus on personalized medicine.
The bone marrow segment is estimated to grow rapidly during
the forecast period.
By cell source, the cell isolation market is segmented into three
segments, namely, adipose tissue, bone marrow, and cord blood/embryonic
stem cells. The bone marrow segment is projected to grow at the highest
rate during the forecast period. This growth is attributed to the
commercialization of a number of bone marrow-derived stem cell-based
products for various therapeutic applications including aGVHD treatment,
cardiovascular disease treatment, wound healing, tissue regeneration,
and musculoskeletal disorders.
The biomolecule isolation segment is estimated to grow
rapidly during the forecast period.
Based on application, the cell isolation market is segmented into
biomolecule isolation, cancer research, stem cell research, tissue
regeneration & regenerative medicine, and in vitro diagnostics. During
the forecast period, the biomolecule isolation segment is estimated to
register the highest growth rate in the overall cell isolation market.
This growth is mainly attributed to the increasing investments by
companies for the production of biopharmaceutical products.
Asia Pacific is estimated to register the highest CAGR
during the forecast period.
In this report, the cell isolation market is segmented into four major
regional segments – North America, Europe, Asia Pacific, and the Rest of
the World (RoW). The market in Asia Pacific is projected to register the
highest growth rate during the forecast period. The growth in this
market is primarily driven by the increasing incidence of chronic and
infectious diseases and a growing population.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Cell Isolation: Market Overview
4.2 North America: Cell Isolation Market, By Product (2018)
4.3 Geographical Snapshot of the Cell Isolation Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Government Funding for Cell-Based Research
5.2.1.2 Increasing Number of Patients Suffering From Cancer and
Infectious Diseases
5.2.1.3 Technological Advancements
5.2.1.4 Growing Focus on Personalized Medicine
5.2.2 Restraints
5.2.2.1 Ethical Issues Related to Embryonic Stem Cell Isolation
5.2.2.2 High Cost of Cell-Based Research
5.2.3 Opportunities
5.2.3.1 Emerging Markets
6 Cell Isolation Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Reagents, Kits, Media, and Sera
6.2.1.1 Owing to the Disposable Nature of Reagents and Assay Kits, This
Market is Driven By Their Consistent Usage and Frequent Purchases
6.2.2 Beads
6.2.2.1 Growing Demand for Magnetic Beads in T-Cell and Stem Cell
Isolation is A Major Factor Driving Growth in This Product Segment
6.2.3 Disposables
6.2.3.1 Increasing Investments in Research By Governments and Companies
are A Major Factor Boosting the Growth of the Cell Isolation Disposables
Market
6.3 Instruments
6.3.1 Centrifuges
6.3.1.1 Growing Use of Centrifuges in the Pharma-Biotech Industry and
Multi-Functionality Options Offered By These Instruments are Driving the
Growth of This Product Segment
6.3.2 Flow Cytometers
6.3.2.1 Launch of Innovative and Cost-Effective Flow Cytometers is
Likely to Drive the Growth of the Market
6.3.3 Magnetic-Activated Cell Separator Systems
6.3.4 Filtration Systems
6.3.4.1 Increasing Research Activities in Cell Biology to Boost the
Market
7 Cell Isolation Market, By Cell Type
7.1 Introduction
7.2 Human Cells
7.2.1 Differentiated Cells
7.2.1.1 Growing Investments By Market Players to Develop New and
Innovative Products is Expected to Support the Growth of the
Differentiated Cell Isolation Market
7.2.2 Stem Cells
7.2.2.1 Rising Government Initiatives Focused on Supporting Stem Cell
Research Expected to Drive Market Growth
7.3 Animal Cells
7.3.1 Biopharmaceutical Companies are the Major End Users of Isolated
Animal Cells
8 Cell Isolation Market, By Cell Source
8.1 Introduction
8.2 Bone Marrow
8.2.1 A Number of Bone Marrow-Derived Stem Cells Have Been
Commercialized in the Last Decade
8.3 Adipose Tissue
8.3.1 Adipose Stem/Stromal Cells Can Generate A Variety of Other Cell
Types
8.4 Cord Blood/Embryonic Stem Cells
8.4.1 Market Growth is Driven By the High Therapeutic Potency of These
Stem Cells
9 Cell Isolation Market, By Technique
9.1 Introduction
9.2 Centrifugation-Based Cell Isolation
9.2.1 Cost-Effectiveness of This Technique in Both Small-Scale and
Large-Scale Operations – A Major Driver
9.3 Surface Marker-Based Cell Isolation
9.3.1 Wide Usage of This Technique in Biopharmaceutical and Biotech
Industries is A Major Reason for the Growth of This Market
9.4 Filtration-Based Cell Isolation
9.4.1 The Major Factor Driving the Growth of This Market Segment is the
Low Cost of the Filtration Technique
10 Cell Isolation Market, By Application
10.1 Introduction
10.2 Biomolecule Isolation
10.2.1 Biomolecule Isolation Dominates the Cell Isolation Applications
Market
10.3 Cancer Research
10.3.1 High Disease Incidence has Fuelled the Demand for Advanced
Treatment
10.4 Stem Cell Research
10.4.1 Increasing Funding in Stem Cell Research to Support Market Growth
10.5 Tissue Regeneration & Regenerative Medicine
10.5.1 Funding for Regenerative Medicine Initiatives has Risen
10.6 in Vitro Diagnostics
10.6.1 Rising Disease Incidence has Driven Demand for Innovative
Therapies and Diagnostics
11 Cell Isolation Market, By End User
11.1 Introduction
11.2 Biotechnology & Biopharmaceutical Companies
11.2.1 Favorable Investments Have Boosted Overall Pace of Research
11.3 Research Laboratories & Institutes
11.3.1 Rising Funding for Cell-Based Research to Drive Market Growth
11.4 Hospitals & Diagnostic Laboratories
11.4.1 Increasing Number of Hospitals in Emerging Countries Will
Contribute to Market Growth
11.5 Other End Users
12 Cell Isolation Market, By Region
13 Competitive Landscape
13.1 Overview
13.2 Market Ranking Analysis, 2017
13.3 Key Strategies
13.3.1 Product Launches, 2015-2018
13.3.2 Expansions, 2015-2018
13.3.3 Partnerships, 2015-2018
13.3.4 Acquisitions, 2015-2018
13.4 Competitive Leadership Mapping (2017)
13.4.1 Vanguards
13.4.2 Innovators
13.4.3 Dynamic Players
13.4.4 Emerging Players
13.5 Competitive Leadership Mapping for Start-Ups (2017)
13.5.1 Progressive Companies
13.5.2 Starting Blocks
13.5.3 Responsive Companies
13.5.4 Dynamic Companies
14 Company Profiles
14.1 Thermo Fisher Scientific, Inc.
14.2 Becton, Dickinson and Company
14.3 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
14.4 Merck KGaA
14.5 Terumo BCT (Subsidiary of Terumo Corporation)
14.6 GE Healthcare
14.7 Bio-Rad Laboratories, Inc.
14.8 Miltenyi Biotec
14.9 Pluriselect Life Science Ug (Haftungsbeschrnkt) & Co. Kg
14.10 Stemcell Technologies, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/3knzz6/global_cell?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology,
Drug
Discovery